Attached files

file filename
EX-5.1 - EX-5.1 - Lipocine Inc.d585873dex51.htm
EX-23.2 - EX-23.2 - Lipocine Inc.d585873dex232.htm
S-1/A - AMENDMENT NO. 1 TO FORM S-1 - Lipocine Inc.d585873ds1a.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Lipocine Inc.:

We consent to the use of our report dated July 24, 2013, with respect to the balance sheets of Lipocine Inc. as of December 31, 2012 and 2011, and the related statements of operations, stockholders’ equity and cash flows for each of the years in the two-year period ended December 31, 2012, included herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Salt Lake City, Utah

September 25, 2013